Beyond Bisphosphonates - New Osteoporosis Medications Under Research: Denosumab and Protelos
For those dissatisfied with current drug options for treating osteoporosis: a new medication being developed by Amgen may be making headway toward the U.S. market. Denosumab, as it is called, would be taken by injection twice a year. The drug inhibits bone remodeling by binding to and thereby blocking the function of a protein known as nuclear... Read more
